News & Updates

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

High-intensity interval (HIIE) and moderate-intensity continuous exercises (MICE) using rope skipping are both effective in improving cardiorespiratory fitness (CRF) in young adults, according to a study. Moreover, both strategies are similarly enjoyable.

Regular coffee consumption appears to be associated with decreases in blood pressure (BP) levels, as according to a Mendelian randomization analysis.

In patients with cardiovascular disease (CVD), reductions in calf and mid-upper arm circumferences are predictive of poor outcomes, according to new research.

Adults who contract respiratory syncytial virus (RSV) infection appear to be at increased risk of cardiovascular events, according to a study.

The oral PCSK9 inhibitor enlicitide lowers LDL-cholesterol (LDL-C) levels and other atherogenic lipids in high-risk patients with hypercholesterolaemia, as shown in the CORALreef Lipids study presented at AHA 2025.

In the treatment of patients with heart failure with reduced ejection fraction (HFrEF) secondary to Chagas disease, the use of sacubitril/valsartan does not appear to lead to improvements in clinical outcomes compared with enalapril, according to a study.

A sedentary behaviour appears to contribute to increased arterial stiffness among older adults, suggests a recent study.

A recent study has shown the association of greater arterial stiffening with both ocular (small) and peripheral (large) fiber neuropathies.

Individuals with a family history of hypertension show increased central and peripheral blood pressure (BP) potentially due to higher systemic vascular resistance (SVR), according to a study. On the other hand, large artery stiffness is not elevated.